Form D · Other Health Care
PNC Podiatry Holdings, LLC
San Francisco, CA · CIK 0001913472
Offering snapshot reported Sep 19, 2024 · SEC filing
- Reported sold
- $188K Offering amount: $188K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 16, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 19, 2024 | Initial | $187,500 | No comparison | 1 | SEC filing |
| Jan 8, 2024 | Initial | $700,000 | No comparison | 1 | SEC filing |
| Dec 28, 2022 | Amendment | $2,758,000 | $1,385,000vs Jul 8, 2022 | 2 | SEC filing |
| Jul 8, 2022 | Amendment | $1,373,000 | $100,000vs Mar 11, 2022 | 2 | SEC filing |
| Mar 11, 2022 | Initial | $1,273,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-524419
Source: Form D, filed Sep 19, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark De Laar | Director |
| Thomas Elardo | Director |
| Corey Golde | Director |
| Kevin Offel | Director |
| Stephen Pohlmeyer | Director, Executive |
| Alexander Reyzelman | Director |
| Chris Roussos | Director |
| Mark Shankar | Director |
| Lowell, Jr. Weil | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2299 Post Street, Suite 205
San Francisco, CA, 94115
San Francisco, CA, 94115